31 filings
8-K
LTRN
Lantern Pharma Inc
18 Mar 24
Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights
4:05pm
8-K
LTRN
Lantern Pharma Inc
29 Dec 23
Departure of Directors or Certain Officers
4:05pm
8-K
LTRN
Lantern Pharma Inc
24 Nov 23
Entry into a Material Definitive Agreement
4:05pm
8-K
LTRN
Lantern Pharma Inc
8 Nov 23
Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights
4:05pm
8-K
LTRN
Lantern Pharma Inc
20 Oct 23
Other Events
5:25pm
8-K
aolog
9 Aug 23
Lantern Pharma Reports Second Quarter 2023 Financial Results and Operational Highlights
4:05pm
8-K
gr4mn2a smazbmdn9sb
21 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
8i9okib6rytm
9 May 23
Lantern Pharma Reports First Quarter 2023 Financial Results and Operational Highlights
4:05pm
8-K
d1ijm1 71
20 Mar 23
Lantern Pharma Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Operational Highlights
4:05pm
8-K
5qmr7527 lqzm1k
18 Jan 23
Departure of Directors or Certain Officers
4:30pm
8-K
nhg ti87t
7 Nov 22
Lantern Pharma Reports Third Quarter 2022 Financial Results and Operational Highlights
4:05pm
8-K
0o0ogs gq5h83b
8 Aug 22
Lantern Pharma Reports Second Quarter 2022 Financial Results and Operational Highlights
4:06pm
8-K
n9lqgbqfq z241nv
14 Jun 22
Submission of Matters to a Vote of Security Holders
7:02am
8-K
ixhfi9szu740vv2i6of8
3 May 22
Lantern Pharma Reports First Quarter 2022 Financial Results and Operational Highlights
4:01pm
8-K
dodeoz i6ky1wrc
26 Apr 22
Lantern Pharma’s Board of Directors Names Maria Maccecchini, Ph.D. as a Director Nominee to Lantern’s Board of Directors
7:15am
8-K
nuoca6 e695umzq
25 Apr 22
Other Events
4:05pm
8-K
lpxud ivk2d
22 Mar 22
Lantern Pharma Announces Extension of Existing Share Repurchase Program
7:01am
8-K
s7d0xn14ew4113
10 Mar 22
Lantern Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Operational Highlights
4:05pm
8-K
22xgx6 0yvwaljgw
24 Jan 22
Other Events
7:01am
8-K
2a9ubnyv1ooe 79
22 Nov 21
Lantern Pharma Announces Share Repurchase Program
9:00am